LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

ProShare Advisors LLC's Holding History (CIK: 0001357955)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 47,966 Value ($000) $26 Avg Close — Range —
Q4 2024
Shares 58,482 Value ($000) $37 Avg Close — Range —
Q3 2024
Shares 45,494 Value ($000) $63 Avg Close — Range —
Q2 2024
Shares 38,982 Value ($000) $57 Avg Close — Range —
Q1 2024
Shares 48,986 Value ($000) $109 Avg Close — Range —
Q4 2023
Shares 44,816 Value ($000) $87 Avg Close — Range —
Q3 2023
Shares 38,957 Value ($000) $57 Avg Close — Range —
Q2 2023
Shares 38,721 Value ($000) $123 Avg Close — Range —
Q1 2023
Shares 37,671 Value ($000) $89 Avg Close — Range —
Q4 2022
Shares 42,884 Value ($000) $149 Avg Close — Range —
Q3 2022
Shares 39,921 Value ($000) $293 Avg Close — Range —
Q2 2022
Shares 38,606 Value ($000) $251 Avg Close — Range —
Q1 2022
Shares 52,739 Value ($000) $267 Avg Close — Range —
Q4 2021
Shares 39,013 Value ($000) $302 Avg Close — Range —